Vermersch, P. and Kappos, L. and Gold, R. and Foley, J. F. and Olsson, T. and Cadavid, D. and Bozic, C. and Richman, S.. (2011) Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy. Neurology, Vol. 76, H. 20. pp. 1697-1704.
Full text not available from this repository.
Official URL: http://edoc.unibas.ch/dok/A6006990
Downloads: Statistics Overview
Abstract
Natalizumab, a therapy for multiple sclerosis (MS), has been associated with progressive multifocal leukoencephalopathy (PML), a rare opportunistic infection of the CNS associated with the JC virus. We assessed clinical outcomes and identified variables associated with survival in 35 patients with natalizumab-associated PML.
Faculties and Departments: | 03 Faculty of Medicine > Bereich Medizinische Fächer (Klinik) > Neurologie > Neuroimmunologie (Kappos) 03 Faculty of Medicine > Departement Klinische Forschung > Bereich Medizinische Fächer (Klinik) > Neurologie > Neuroimmunologie (Kappos) |
---|---|
UniBasel Contributors: | Kappos, Ludwig |
Item Type: | Article, refereed |
Article Subtype: | Research Article |
Publisher: | Lancet Publications |
ISSN: | 0028-3878 |
Note: | Publication type according to Uni Basel Research Database: Journal article |
Identification Number: | |
Last Modified: | 06 Dec 2013 09:36 |
Deposited On: | 06 Dec 2013 09:36 |
Repository Staff Only: item control page